Document
CBM2014-00151, No. 4 Power of Attorney - Power of Attorney (P.T.A.B. Jul. 9, 2014)
Cite Document
CBM2014-00151, No. 4 Power of Attorney - Power of Attorney (P.T.A.B. Jul. 9, 2014)
+ More Snippets
Document
CBM2014-00151, No. 2 Petition - Exhibit List (P.T.A.B. Jul. 9, 2014)
Cite Document
CBM2014-00151, No. 2 Petition - Exhibit List (P.T.A.B. Jul. 9, 2014)
+ More Snippets
Document
CBM2014-00151, No. 2003 Exhibit - Centers for Disease Control, Gamma Hydroxy Butyrate Use, New York and Texas, 1995 1996, MMWR 4613 281 83 Apr 4, 1997 (P.T.A.B. Oct. 21, 2014)
Cite Document
CBM2014-00151, No. 2003 Exhibit - Centers for Disease Control, Gamma Hydroxy Butyrate Use, New York and Texas, 1995 1996, MMWR 4613 281 83 Apr 4, 1997 (P.T.A.B. Oct. 21, 2014)
+ More Snippets
Document
CBM2014-00151, No. 2012 Exhibit - 146 Cong Rec H55 62 daily ed Jan 31, 2000 (P.T.A.B. Oct. 21, 2014)
Cite Document
CBM2014-00151, No. 2012 Exhibit - 146 Cong Rec H55 62 daily ed Jan 31, 2000 (P.T.A.B. Oct. 21, 2014)
+ More Snippets
Document
CBM2014-00151, No. 1004 Exhibit - FDA Advisory Committee Preliminary Clinical Safety Review (P.T.A.B. Jul. 9, 2014)
Cite Document
CBM2014-00151, No. 1004 Exhibit - FDA Advisory Committee Preliminary Clinical Safety Review (P.T.A.B. Jul. 9, 2014)
+ More Snippets
Document
CBM2014-00151, No. 1023 Exhibit - FDA Approved Labeling (P.T.A.B. Jul. 9, 2014)
Cite Document
CBM2014-00151, No. 1023 Exhibit - FDA Approved Labeling (P.T.A.B. Jul. 9, 2014)
+ More Snippets
Document
CBM2014-00151, No. 1001 Exhibit - US Patent No 7,668,730 (P.T.A.B. Jul. 9, 2014)
Cite Document
CBM2014-00151, No. 1001 Exhibit - US Patent No 7,668,730 (P.T.A.B. Jul. 9, 2014)
+ More Snippets
Document
CBM2014-00151, No. 2010 Exhibit - Date Rape Drugs, Hearing Before the Subcomm on Oversight Investigations of the H Comm on Commerce, 106th Cong Mar 11, 1999 (P.T.A.B. Oct. 21, 2014...
Cite Document
CBM2014-00151, No. 2010 Exhibit - Date Rape Drugs, Hearing Before the Subcomm on Oversight Investigations of the H Comm on Commerce, 106th Cong Mar 11, 1999 (P.T.A.B. Oct. 21, 2014)
+ More Snippets
Document
CBM2014-00151, No. 2014 Exhibit - Letter from Dr Russell Katz, Director, Division of Neurology Products, ODE I, to Dr Dayton T Reardan, Orphan Medical, Inc Nov 18, 2005 (P.T.A.B. Oct. 21, 20...
Cite Document
CBM2014-00151, No. 2014 Exhibit - Letter from Dr Russell Katz, Director, Division of Neurology Products, ODE I, to Dr Dayton T Reardan, Orphan Medical, Inc Nov 18, 2005 (P.T.A.B. Oct. 21, 2014)
+ More Snippets
Document
CBM2014-00151, No. 1015 Exhibit - 66 Fed Reg 24391 (P.T.A.B. Jul. 9, 2014)
Cite Document
CBM2014-00151, No. 1015 Exhibit - 66 Fed Reg 24391 (P.T.A.B. Jul. 9, 2014)
+ More Snippets
Document
CBM2014-00151, No. 1017 Exhibit - FDA Advisory Committee Meeting Documents by Center (P.T.A.B. Jul. 9, 2014)
Cite Document
CBM2014-00151, No. 1017 Exhibit - FDA Advisory Committee Meeting Documents by Center (P.T.A.B. Jul. 9, 2014)
+ More Snippets
Document
CBM2014-00151, No. 2018 Exhibit - Wayback Machine, Archive of the URL corresponding to PAR1005 (P.T.A.B. Oct. 21, 2014)
Cite Document
CBM2014-00151, No. 2018 Exhibit - Wayback Machine, Archive of the URL corresponding to PAR1005 (P.T.A.B. Oct. 21, 2014)
+ More Snippets
Document
CBM2014-00151, No. 2007 Exhibit - SAMHSA, Advisory, GHB A Club Drug to Watch Nov 2002 (P.T.A.B. Oct. 21, 2014)
Cite Document
CBM2014-00151, No. 2007 Exhibit - SAMHSA, Advisory, GHB A Club Drug to Watch Nov 2002 (P.T.A.B. Oct. 21, 2014)
+ More Snippets
Document
CBM2014-00151, No. 1024 Exhibit - Intentionally Left Blank (P.T.A.B. Jul. 9, 2014)
Cite Document
CBM2014-00151, No. 1024 Exhibit - Intentionally Left Blank (P.T.A.B. Jul. 9, 2014)
+ More Snippets
Document
CBM2014-00151, No. 1021 Exhibit - Orange Book Entries for Xyrem (P.T.A.B. Jul. 9, 2014)
Cite Document
CBM2014-00151, No. 1021 Exhibit - Orange Book Entries for Xyrem (P.T.A.B. Jul. 9, 2014)
+ More Snippets